Details for New Drug Application (NDA): 076375
NDA 076375 describes RIMANTADINE HYDROCHLORIDE, which is a drug marketed by Chartwell Rx, Impax Labs, and Impax Labs Inc, and is included in three NDAs. It is available from one supplier. Additional details are available on the RIMANTADINE HYDROCHLORIDE profile page.
The generic ingredient in RIMANTADINE HYDROCHLORIDE is rimantadine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the rimantadine hydrochloride profile page.
The generic ingredient in RIMANTADINE HYDROCHLORIDE is rimantadine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the rimantadine hydrochloride profile page.
Summary for 076375
| Tradename: | RIMANTADINE HYDROCHLORIDE |
| Applicant: | Chartwell Rx |
| Ingredient: | rimantadine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 076375
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Jan 14, 2003 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
